Templeton, ICICI's Bet on Indian Pharma Redemption Pays in Rally


India's pharmaceutical industry is helping lead an equity bull run as investors wager on a resolution to U.S. regulatory sanctions that rocked companies in the sector last year. Franklin Templeton Investment's biggest India stock fund added to its holdings of Dr. Reddy's Laboratories Ltd. in November, when the stock plunged 27 percent, building it up by more than half through the first quarter of this year.



from Biotech News